Chinese start evaluation of Calypte HIV urine test
This article was originally published in Clinica
China's national centre for AIDS prevention and control has begun evaluating Calypte Biomedical's urine-based test system for HIV-1. The centre will assess the accuracy of the assay using Chinese patient samples and will recommend the introduction of a national testing programme if trials with the product are successful.
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.